[company_age]unknown[/company_age][employees]11-50 employees[/employees][funding]Series B[/funding][description]WhiteSwell is a medical technology company dedicated to revolutionizing the treatment of acute decompensated heart failure (ADHF), a prevalent condition leading to frequent hospital readmissions and emergency room visits. Their pioneering approach involves a minimally invasive catheter-based system, the eLym™, designed to enhance the lymphatic system's natural fluid removal process, effectively addressing the root cause of ADHF – fluid overload. This sets them apart from competitors who primarily focus on symptom management through diuretics or other therapies. WhiteSwell's unique solution targets the underlying issue, potentially leading to significant improvements in patient outcomes.[/description][ps]eLym™ System - Minimally invasive catheter-based system for ADHF treatment.[/ps]